Shares of Encompass Health Corporation (NYSE:EHC – Get Free Report) have been given a consensus recommendation of “Buy” by the nine brokerages that are covering the firm, Marketbeat Ratings reports. Seven analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $127.00.
Several brokerages have weighed in on EHC. Wall Street Zen lowered Encompass Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 6th. KeyCorp increased their price objective on Encompass Health from $122.00 to $135.00 and gave the company an “overweight” rating in a report on Tuesday, May 27th. Royal Bank Of Canada raised their price objective on Encompass Health from $110.00 to $125.00 and gave the company an “outperform” rating in a research note on Monday, April 28th. Truist Financial reissued a “buy” rating and issued a $135.00 price objective (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Finally, Barclays raised their price objective on Encompass Health from $118.00 to $129.00 and gave the company an “overweight” rating in a research note on Friday, April 25th.
Get Our Latest Stock Report on Encompass Health
Encompass Health Price Performance
Encompass Health (NYSE:EHC – Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.18. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same period in the previous year, the firm posted $1.12 earnings per share. The firm’s revenue was up 10.6% on a year-over-year basis. On average, analysts forecast that Encompass Health will post 4.8 earnings per share for the current year.
Encompass Health Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.56%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health’s dividend payout ratio is currently 14.05%.
Insiders Place Their Bets
In other Encompass Health news, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president now directly owns 79,710 shares of the company’s stock, valued at $9,149,910.90. The trade was a 11.15% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the business’s stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the sale, the insider now owns 11,958 shares in the company, valued at approximately $1,394,422.38. This represents a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock valued at $16,034,082 in the last three months. Company insiders own 2.00% of the company’s stock.
Institutional Trading of Encompass Health
Institutional investors and hedge funds have recently modified their holdings of the company. Charles Schwab Investment Management Inc. increased its position in shares of Encompass Health by 0.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 644,764 shares of the company’s stock valued at $59,544,000 after purchasing an additional 4,345 shares during the period. Fifth Third Bancorp increased its position in shares of Encompass Health by 88.7% during the first quarter. Fifth Third Bancorp now owns 4,290 shares of the company’s stock valued at $434,000 after purchasing an additional 2,017 shares during the period. BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Encompass Health during the fourth quarter valued at approximately $4,160,000. US Bancorp DE boosted its stake in Encompass Health by 9.6% in the 4th quarter. US Bancorp DE now owns 1,380 shares of the company’s stock valued at $127,000 after buying an additional 121 shares in the last quarter. Finally, Farallon Capital Management LLC boosted its stake in Encompass Health by 15,266.7% in the 4th quarter. Farallon Capital Management LLC now owns 461,000 shares of the company’s stock valued at $42,573,000 after buying an additional 458,000 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Read More
- Five stocks we like better than Encompass Health
- Where Do I Find 52-Week Highs and Lows?
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- The Significance of Brokerage Rankings in Stock Selection
- Is IBM’s AI Transformation Powering a Sustained Rally?
- Pros And Cons Of Monthly Dividend Stocks
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.